Assessment of the mortality rates and associated risk factors in laboratory-confirmed cases of covid-19: An institutional study

Abstract

Background: To decrease complications and mortality of COVID-19 infection, early diagnosis and severity prediction are the keys. Aims and Objectives: The present study was conducted to assess the clinical profile and outcomes of COVID-19 cases admitted to SMBT COVID care center. Materials and Methods:In 487 subjects from both genders within the age group of 19-89 years, demographics including gender, age, and socioeconomic status were recorded along with Neutrophils, lymphocytes, and NLR. Further, the severity and mortality were assessed based on age, comorbidities, and gender. The collected data were subjected to statistical evaluation and the results were formulated. Results: 61.60% (n=300) of subjects survived and were discharged. The mortality rate in subjects with comorbidities was 62.03% (n=116) and without comorbidities was 37.96% (n=71). Higher mortality rates were seen in males with 66.84% (n=125) deaths compared to females with 36.36% (n=62) deaths. Significantly higher deaths were seen in subjects older than 50 years with 66.31% (n=124) deaths, whereas, lesser deaths were seen in subjects who were aged 50 years or less with 33.68% (n=63) deaths. This difference was statistically significant with p<0.001. Conclusion: Within its limitations, the present study concludes that higher mortality rates are associated with male gender, presence of comorbidities, and older age in subjects with COVID-19.